# Athyrium Capital Management: portfolio, investments and team > Athyrium Capital Management is a private equity based in United States. 5 investments on record, latest Mar 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/athyrium-capital-management-lp (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Athyrium Capital Management Last cheque observed Mar 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds. Email Quiet Private equity Seed Series A Series B Wellness Health Tech-enabled Health Follow Athyrium Capital Management and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fathyrium-capital-management-lp) Cheques on record **0%** of best year **0** **cheques in 12 months**, 5 on record Since the last cheque **2797** days **00** hrs **00** min **00** sec Median round **$90M** Rounds led **0 of 5** Sole investor **4 rounds** Mostly in **United States, 100%** Pitch Athyrium Capital Management ## Athyrium Capital Management highlights - 01 5 rounds on record - 02 Mostly Debt and Venture: 100% of its rounds - 03 Sole investor in 4 rounds, median $48M ## What they do > Athyrium Capital Management is a leading investment management platform dedicated to global opportunities in the healthcare sector. From their own website - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B - **Sectors:** Wellness Health Tech-enabled Health - **Based in:** New York, United States - **Cold pitches:** Not accepted ## The record Every round we can evidence, newest first **5 appearances** - **2019** 1 round - **Mar** **[Secura Bio](https://millionrounds.com/company/secura-bio)** Debt · US · FinSMEs **$145M** Sole investor - **2018** 1 round - **Jul** **[Agendia](https://millionrounds.com/company/agendia)** US · FinSMEs **$35M** Sole investor - **2015** 2 rounds - **Sept** **[Clover Health](https://millionrounds.com/company/clover-health)** Venture · US **$100M** With 1 other - **Mar** **[Apollo Endosurgery](https://millionrounds.com/company/apollo-endosurgery)** Debt · US **$50M** Sole investor - **2014** 1 round - **Jul** **[Retrophin](https://millionrounds.com/company/retrophin)** Debt · US **$46M** Sole investor An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **5 named** AC **Andrew Cooper Hyman** Chief Compliance Officer i Form ADV CA **Courtney Anne Paul** Vice President and Assistant Secretary i Form ADV EM **Elin Mydland Strong** Senior Vice President i Form ADV JA **Jeffrey Allen Ferrell** President i Form ADV RJ **Rashida Jamelia Adams** Vice President i Form ADV We also hold **35** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$2.5B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Athyrium Capital Management LP - **SEC number:** CRD 161528 Funds on its Form ADV **8** private funds, **$2.9B** in gross assets · filed Sept 2024 Hedge **7** Private equity **1** - Athyrium Opportunities Fund IV Master (NON-US) L.P. *Hedge* 24 investors $1.1B - Athyrium Opportunities Fund III Master (NON-US) L.P. *Hedge* 16 investors $726M - Athyrium Opportunities Fund III L.P. *Hedge* 25 investors $289M - Athyrium Opportunities Fund II Master (NON-US) L.P. *Hedge* 21 investors $249M - Athyrium Opportunities Fund IV L.P. *Hedge* 5 investors $193M - Athyrium Opportunities Fund II L.P. *Hedge* 32 investors $153M - Athyrium Opportunities IV Co-Invest A L.P. *Private equity* 1 investor $102M - Athyrium Opportunities Fund II-B Master L.P. *Hedge* 2 investors $46M ## What they claim to have backed From their own portfolio page (on their website) **26** of 60 we have independently watched raise [Agendia](https://millionrounds.com/company/agendia)[Alcresta](https://millionrounds.com/company/alcresta)[Amrytpharma](https://millionrounds.com/company/amryt-pharma)[Bioclinica](https://millionrounds.com/company/bioclinica)[Bionpharma](https://millionrounds.com/company/bion-pharma)[Bridgebio](https://millionrounds.com/company/bridgebio)[Clario](https://millionrounds.com/company/clario)[Cloverhealth](https://millionrounds.com/company/clover-health)[Dermira](https://millionrounds.com/company/dermira)[Hlstherapeutics](https://millionrounds.com/company/hls-therapeutics)[Horizonpharma](https://millionrounds.com/company/horizon-pharma)[Medicrea](https://millionrounds.com/company/medicrea)[Navihealth](https://millionrounds.com/company/navihealth)[Omeros](https://millionrounds.com/company/omeros)[Optinose](https://millionrounds.com/company/optinose)[Ouitherapeutics](https://millionrounds.com/company/oui-therapeutics)[Portola](https://millionrounds.com/company/portola)[Pumabiotechnology](https://millionrounds.com/company/puma-biotechnology)[Securabio](https://millionrounds.com/company/secura-bio)[Triabeauty](https://millionrounds.com/company/tria-beauty)[Umotif](https://millionrounds.com/company/umotif)[Universalbiosensors](https://millionrounds.com/company/universal-biosensors)[Valneva](https://millionrounds.com/company/valneva)[Villagemd](https://millionrounds.com/company/villagemd)[Vitahealth](https://millionrounds.com/company/vita-health)[Zealandpharma](https://millionrounds.com/company/zealand-pharma) Alvogen Amagpharma Apolloendo Aquadermatology Arisglobal Azurity Basf Basilea Bendbioscience Bioratherapeutics Calliditas Centinelspine Choicehealthathome Cipherpharma Coherus Completehealth Dupagemedicalgroup Elara Esperion Galenica Gentivahs Halozyme Healthsun Heartlandvetpartners Indivior Innopharmainc Innovacarehealth Ironwoodpharma Leonmedicalcenters Longevityhealthplan Obhg Paratekpharma Pharmerica Ptcbio and 15 more Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## The cheque Seed Series A Series B Median round joined **$90M** the round, not its cheque Alone, median **$48M** Led 0 of 5 rounds **0%** - **Sole investor:** 4 rounds - **Last cheque:** Mar 2019 Rounds by stage said on their site - Debt *3* - Venture *1* - Seed said *-* - Series A said *-* - Series B said *-* Cheques by year Led Joined 2014 2019 **Pitching Athyrium Capital Management?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Recently backed The latest companies Athyrium Capital Management put money into. [**Secura Bio** $145M · Mar 2019](https://millionrounds.com/company/secura-bio)[**Agendia** $35M · Jul 2018](https://millionrounds.com/company/agendia) ## Quick answers about Athyrium Capital Management ### What does Athyrium Capital Management invest in? Athyrium Capital Management invests most often at Debt and Venture (100% of the rounds on record), in sectors such as Wellness, Health and Tech-enabled Health. ### How active is Athyrium Capital Management? 5 investments on record, 0 of them in the last 12 months. The most recent was in Mar 2019. ### What has Athyrium Capital Management invested in recently? Its most recent investments on record: Secura Bio (Debt, Mar 2019) and Agendia (Undisclosed round, Jul 2018). ### How big are Athyrium Capital Management's cheques? The median round it joins is $90M. ### Does Athyrium Capital Management lead rounds? Rarely, if at all: none of its 5 investments on record names it as the lead. ### Where does Athyrium Capital Management invest? Most of the companies it backs are in the United States (100%). ### Is Athyrium Capital Management investing now? No investments in the last 12 months; the latest was in Mar 2019. ### What kind of investor is Athyrium Capital Management? Athyrium Capital Management is a private equity firm based in New York, United States. ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=athyrium-capital-management-lp) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=athyrium-capital-management-lp)